Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Exoskeleton Neurogenic Bowel Dysfunction Study

NCT: NCT05176327 · COMPLETED

NCT IDNCT05176327
StatusCOMPLETED
Start Date2022-01-01
Completion2024-07-31

Brief Summary

The purpose of the study is to assess the effects of exoskeleton training on neurogenic bowel disorders in spinal cord injury/ disease.

Frequently Asked Questions

What is Exoskeleton Neurogenic Bowel Dysfunction Study?

Exoskeleton Neurogenic Bowel Dysfunction Study is a clinical trial registered under NCT05176327. Current status: COMPLETED.

What is the status of NCT05176327?

The current status of NCT05176327 (Exoskeleton Neurogenic Bowel Dysfunction Study) is: COMPLETED.

When did Exoskeleton Neurogenic Bowel Dysfunction Study start?

Exoskeleton Neurogenic Bowel Dysfunction Study started on 2022-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑